International Stem Cell Corporation Opens Facility for Development and Production of Clinical-Grade Stem Cell Products

OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners’ clinical-grade stem cell products.

MORE ON THIS TOPIC